ADIPOQ and cancer: Results showed that circulating HMW-adiponectin levels in cancer cases were significantly lower than in the controls with a pooled SMD of −0.502 μg/ml (95% CI, −0.957 to −0.047, P = 0.000), which is consistent with the results derived from total adiponectin levels.